I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Treatment Effectiveness and Tolerability of Long-term Adjuv..:
Jing-Ren Ye
;
Pei-Hsing Chen
;
Jen-Hao Chuang
...
https://www.frontiersin.org/articles/10.3389/fsurg.2022.816018/full. , 2022
Link:
https://doi.org/10.3389/fsurg.2022.816018
RT Journal T1 <Title>Treatment Effectiveness and Tolerability of Long-term Adjuvant First- and Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor at Different Doses in Patients With Stage IIA–IIIB Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Retrospective Study</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:407b2f3569724cb184ebc2295ffda1a9&Exemplar=1&LAN=DE A1 Jing-Ren Ye A1 Pei-Hsing Chen A1 Jen-Hao Chuang A1 Mong-Wei Lin A1 Tung-Ming Tsai A1 Hsao-Hsun Hsu A1 Jin-Shing Chen PB Frontiers Media S.A. YR 2022 K1 adjuvant therapy K1 epidermal growth factor receptor-tyrosine kinase inhibitor K1 non-small-cell lung carcinoma K1 thoracic surgery K1 advanced lung cancer K1 Surgery K1 RD1-811 JF https://www.frontiersin.org/articles/10.3389/fsurg.2022.816018/full LK http://dx.doi.org/https://doi.org/10.3389/fsurg.2022.816018 DO https://doi.org/10.3389/fsurg.2022.816018 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
